Pharmacokinetic evaluation of capecitabine in breast cancer-Reference-Cited by-同舟云学术

Pharmacokinetic evaluation of capecitabine in breast cancer

Published:2013-01-10 Issue:2 Volume:9 Page:225-235
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Daniele Gennaro,Gallo Marianna,Piccirillo Maria Carmela,Giordano Pasqualina,D'Alessio Amelia,Del Giudice Antonia,La Porta Maria Libera,Perrone Francesco,Normanno Nicola,De Luca Antonella

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2013.759939

Reference69 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies

2. Dose intensity for bolus versus infusion chemotherapy administration: Review of the literature for 27 anti-neoplastic agents

3. The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, Capecitabine

4. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

5. Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of bioequivalence and safety analysis of capecitabine tablets and Xeloda® under postprandial dosing conditions in Chinese patients with solid tumor;Expert Opinion on Drug Metabolism & Toxicology;2023-12-02

2. Photodynamic Therapy of Breast Cancer in Animal Models and Their Potential Use in Clinical Trials—Role of the Photosensitizers: A Review;Frontiers in Bioscience-Landmark;2023-07-21

3. In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting;IRAN J BASIC MED SCI;2021

4. Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients;Istanbul Journal of Pharmacy;2019-09-06

5. PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway;Cancer Biology & Therapy;2018-01-25